For the fiscal year ending March 2026, consolidated net sales were \u00a5137,851 million (15.8% YoY increase), operating income was \u00a532,529 million (47.4% YoY increase), and net income attributable to owners of parent was \u00a524,011 million (122.7% YoY increase).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4626","jir_company_name":"Taiyo Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-04-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/4626-20260430-01.pdf","jir_short_summary":"For the fiscal year ending March 2026, consolidated net sales were \u00a5137,851 million (15.8% YoY increase), operating income was \u00a532,529 million (47.4% YoY increase), and net income attributable to owners of parent was \u00a524,011 million (122.7% YoY increase).","jir_summary":"### Overview of Results\nFor the fiscal year ending March 2026, consolidated results were net sales of \u00a5137,851 million (15.8% YoY increase), operating income of \u00a532,529 million (47.4% YoY increase), ordinary income of \u00a532,244 million (49.4% YoY increase), and net income attributable to owners of parent of \u00a524,011 million (122.7% YoY increase). In the Electronics segment, increased sales volume of dry film products for semiconductor memory driven by AI adoption contributed positively. The Medical and Pharmaceutical segment saw revenue growth led by increased outsourcing volume in contract manufacturing. Special gains include gains on liquidation of affiliated companies, and special losses include corporate action expenses.\n\n### Outlook and Dividend Policy\nFor the fiscal year ending March 2027, consolidated earnings forecasts are net sales of \u00a5146,300 million (6.1% YoY increase), operating income of \u00a534,300 million (5.4% YoY increase), ordinary income of \u00a533,400 million (3.6% YoY increase), and net income attributable to owners of parent of \u00a524,100 million (0.4% YoY increase). The exchange rate assumption is \u00a5150.0 per US dollar. An increase in sales and profit is expected in the Electronics segment, while the Medical and Pharmaceutical segment is forecasted to record revenue growth but a decrease in profit. Regarding dividends, no year-end dividend was paid for FY March 2026, and no interim or year-end dividends are planned for FY March 2027.","jir_financial_highlights":"Net Sales: \u00a5137,851 million (15.8% YoY increase)\nOperating Income: \u00a532,529 million (47.4% YoY increase)\nOrdinary Income: \u00a532,244 million (49.4% YoY increase)\nNet Income Attributable to Owners of Parent: \u00a524,011 million (122.7% YoY increase)\nNet Income Per Share: \u00a5215.92 (Increase YoY)\nEquity Ratio: 57.3% (Increase YoY)\nDividend (Interim): \u00a5165 (Increase YoY)\nDividend (Year-end): \u00a50 (Decrease YoY (No year-end dividend))\nNumber of Outstanding Shares at Year-end: 116,839,616 shares (Increase YoY)","jir_category":"","jir_hashtags":"#TaiyoHoldings, #FinancialSummary, #JapaneseStocks","jir_key_figures":"Net Sales: \u00a5137,851 million (15.8% YoY increase)\nOperating Income: \u00a532,529 million (47.4% YoY increase)\nNet Income Attributable to Owners of Parent: \u00a524,011 million (122.7% YoY increase)","jir_meta_title":"Taiyo Holdings FY March 2026 Financial Results | Net Sales \u00a5137.85 Billion (+15.8% YoY)","jir_meta_description":"Taiyo Holdings Co., Ltd. FY March 2026 Financial Summary. Reported net sales of \u00a5137,851 million (15.8% YoY increase), operating income of \u00a532,529 million (47.4% YoY increase), and net income of \u00a524,011 million (122.7% YoY increase).","jir_og_title":"Taiyo Holdings FY March 2026 Financial Results | Net Sales \u00a5137.85 Billion (+15.8% YoY)","jir_og_description":"Taiyo Holdings FY March 2026 Financial Summary. Achieved revenue and profit growth with operating income of \u00a532,529 million and net income of \u00a524,011 million.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY March 2025\\\",\\\"FY March 2026\\\",\\\"FY March 2027 Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[119010,137851,146300],\\\"borderColor\\\":\\\"#007bff\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY March 2025\\\",\\\"FY March 2026\\\",\\\"FY March 2027 Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[22067,32529,34300],\\\"borderColor\\\":\\\"#28a745\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}}}}\"}, {\"jir_chart_id\": \"net_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY March 2025\\\",\\\"FY March 2026\\\",\\\"FY March 2027 Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income\\\",\\\"data\\\":[10780,24011,24100],\\\"borderColor\\\":\\\"#dc3545\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Electronics Segment\\\",\\\"Medical and Pharmaceutical Segment\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"FY March 2025\\\",\\\"data\\\":[81203,31558],\\\"backgroundColor\\\":[\\\"#007bff\\\",\\\"#28a745\\\"]},{\\\"label\\\":\\\"FY March 2026\\\",\\\"data\\\":[95285,36490],\\\"backgroundColor\\\":[\\\"#0056b3\\\",\\\"#1e7e34\\\"]}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}}}}\"}, {\"jir_chart_id\": \"operating_profit_margin\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Profit Margin Trend (%)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY March 2025\\\",\\\"FY March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Profit Margin\\\",\\\"data\\\":[18.5,23.6],\\\"borderColor\\\":\\\"#ffc107\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}}}}\"}]","ir_related_company":7826,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-44011","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n